Understanding Melanoma

Sugar Pill Myth: What Am I Really Getting in a Clinical Trial?

One barrier to clinical trial enrollment is the myth that patients might receive a sugar pill and get no treatment at all. Watch as Dr. Heather Wakelee lays out the clinical trial facts.

Published:

Clinical Trial MythBusters: Which Factors Can Exclude Me From a Trial?

What is the criteria for participating in a clinical trial? In this Clinical Trial MythBusters, Dr. Heather Wakelee explains trial eligibility and why they’re designed this way.

Published:

How Do I Navigate Clinical Trials That Are Right for Me?

The search for the right clinical trial can be overwhelming. Tune in to hear from Tricia Holtz as she shares a valuable resource for patients to help guide the decision-making process and to find a trial that’s right for them.

Published:

Clinical Trial MythBusters: How Have Clinical Trials Evolved?

The design of clinical trials had to adapt to better meet the needs of both patients and health experts. Find out from Dr. Heather Wakelee how the field has changed.

Published:

Melanoma Patient Network: Sharing Medical Information With Patients

What are the best ways to understand melanoma and melanoma treatments? Bettina Ryll of the Melanoma Patient Network Europe explains how to become an empowered patient.

Published:

Clinical Trial MythBusters: "Without Clinical Trials There Is No Advancement"

Dr. Liza Villaruz, Sheila Hoff and patient, Dr. Michael Weitz discuss whether clinical trials are a gamble and whether the risks outweigh the benefits for patients and their care partners.

Published:

Are Clinical Trials Only for Patients at a Certain Stage of Disease?

Dr. Liza Villaruz and Sheila Hoff discuss whether clinical trials are available to patients as a treatment option for different stages of disease and whether the risks outweigh the benefits for patients and their care partners.

Published:

Clinical Trial MythBusters: Are Clinical Trials a Gamble for Me or My Loved One?

Dr. Liza Villaruz, Sheila Hoff and patient, Dr. Michael Weitz discuss whether clinical trials are a gamble and whether the risks outweigh the benefits for patients and their care partners.

Published:

Promising News in Melanoma From ASCO 2017

As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Ryan Sullivan from Massachusetts General Hospital Cancer Center provides a positive update for melanoma patients.

Published:

Showing 9 of 62 programs
Advertisement
Join Our Community Register For Events Read Our Latest Blog
Advertisement

Page last updated on November 7, 2013